(Q50787658)

19 March 2018

review article

1 reference

title

[Age-related macular degeneration: a socioeconomic time bomb in our aging society]. (English)

1 reference

19 March 2018

0 references

1 reference

W F Schrader

1

1 reference

19 March 2018

language of work or name

German

0 references

publication date

1 September 2006

1 reference

19 March 2018

published in

Ophthalmologe

1 reference

19 March 2018

volume

103

1 reference

19 March 2018

issue

9

1 reference

19 March 2018

page(s)

742-748

1 reference

19 March 2018

https://scigraph.springernature.com/pub.10.1007/s00347-006-1418-4

exact match

0 references

cites work

The Grading and Prevalence of Macular Degeneration in Chesapeake Bay Watermen

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00347-006-1418-4

[Low vision--management of visually impaired patients by magnifying vision aids. I: Physiological and optical basic principles]

21 January 2018

1 reference

12 December 2020

1 reference

12 December 2020

[Introduction to the topic: Off-label use of bevacizumab in the treatment of neovascular age-related macular degeneration]

1 reference

12 December 2020

The Framingham Eye Study monograph: An ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975

1 reference

12 December 2020

Prevalence of age-related macular degeneration in the United States

1 reference

12 December 2020

The cost-utility of photodynamic therapy in eyes with neovascular macular degeneration--a value-based reappraisal with 5-year data

1 reference

12 December 2020

Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE).

1 reference

12 December 2020

The Position of the Retinological Society, the German Ophthalmological Society and the Professional Association of Ophthalmologists--comments on the current therapy for neovascular AMD

1 reference

12 December 2020

[New blindness incidents in Württemberg-Hohenzollern]

1 reference

12 December 2020

Prevalence of age-related maculopathy. The Beaver Dam Eye Study

1 reference

12 December 2020

Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therap

1 reference

12 December 2020

The prevalence of age-related maculopathy in the Rotterdam Study

1 reference

12 December 2020

Impact of bilateral visual impairment on health-related quality of life: the Blue Mountains Eye Study

1 reference

12 December 2020

Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.

1 reference

12 December 2020

10.1007/S00347-006-1418-4

Identifiers

DOI

1 reference

19 March 2018

1 reference

19 March 2018